Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon
| Autor: | Wilfred Lik-Man Mui, Chuen Hing Lam, Man Yee Yung, Enders K.W. Ng, Bonnie Y. Tsung |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Adult
Male medicine.medical_specialty Waist Endocrinology Diabetes and Metabolism Comorbidity Gastroenterology Body Mass Index Quality of life Weight loss Diabetes mellitus Internal medicine Weight Loss medicine Humans Gastric Balloon Nutrition and Dietetics Anthropometry business.industry medicine.disease Obesity Obesity Morbid Surgery Treatment Outcome Blood pressure Quality of Life Female medicine.symptom Metabolic syndrome business Body mass index |
| Zdroj: | Obesity Surgery. 20:1128-1132 |
| ISSN: | 1708-0428 0960-8923 |
| DOI: | 10.1007/s11695-008-9766-6 |
| Popis: | Background The impact of intragastric balloon (IGB) on obesity-related illnesses and quality of life (QOL) has not been previously investigated. Method One hundred and nineteen consecutive obese patients (86 females; mean age 37.8; mean body weight (BW) 103.7±24.1 kg; mean BMI 38.4±8.0 kg/m 2 ) who underwent IGB were evaluated for improvement on obesity-related illnesses and QOL after weight reduction in a multidisciplinary university referral center. Bioenterics Intragastric balloon (BIB®) system was employed in the study. Results Mean treatment period was 169.9±34.8 days. Mean BW, BMI, and excess body weight loss were 12.4±6.9 kg, 4.6±2.7 kg/m 2 , and 45.1±35.3%. Mean waist circumference and biceps fold and triceps fold loss were 10.5±8.3, 9.8± 8.5, and 8.7±7.4 cm respectively. Metabolic syndrome was decreased from 42.9% to 15.1% after IGB (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink